Mice transgenic for MUC1 (mucin 1) and polyomavirus middle T (PyMT) develop mammary carcinomas within 15 weeks with 100% penetrance. PyMT-induced mammary tumorigenesis is closely correlated with robust telomerase expression and activity. To assess the role of telomerase activation and telomere maintenance in mammary carcinoma tumorigenesis, we generated mice expressing MUC1 and PyMT (MMT mice) but deficient in the telomerase RNA component, mTerc, on the C57BL/6 background. Successive generational intercrosses of mTerc MMT ¼ 98.6 days versus G1, G2, G3 and G4 mTerc À/À MMT mice with latencies of 122.6, 138.9, 140.7 and 220.9 days, respectively (controls versus G1-G4, Po0.005). The progressive impairment of lung metastasis was also observed with each successive mTerc À/À MMT generation. The impairment of tumorigenesis was associated with decreased proliferation of mammary epithelial and tumor cells and increased apoptosis of tumor cells. Together, these results indicate that, in the setting of viral oncoprotein mammary tumorigenesis, telomerase-dependent telomere maintenance facilitates the formation and metastatic progression of mammary tumors.
Introduction
Telomeres consist of guanine-rich tandem repeats that prevent chromosome ends from being recognized as DNA double-strand (dsDNA) breaks by acting as docking points for the protein complex shelterin (de Lange, 2005 ). McClintock's historical observation that the loss of telomeric sequences in maize chromosomes renders DNA ends recombinogenic highlighted the importance of telomeres and their associated complexes in chromosomal integrity (McClintock, 1941) . In the past decade, numerous studies have shown that telomere erosion is one of the main mechanisms underlying genomic instability and therefore an important factor in cancer initiation and progression (Blasco et al., 1997; Rudolph et al., 1999; Hanahan and Weinberg, 2000; DePinho and Polyak, 2004; Meeker and Argani, 2004) . Telomeres are maintained by a specialized reverse transcriptase, the ribonucleoprotein telomerase. Telomerase is composed of an RNA template called telomerase RNA component (Terc) and a protein catalytic subunit called telomerase reverse transcriptase (Tert) (Greider and Blackburn, 1987) . Telomerase activity is robust in mitotically active cells such as germ cells, stem cells and tumor cells, but low or absent in most human somatic tissues (Kim et al., 1994) . In primary human cells, the progressive erosion of telomeres triggers replicative senescence and cell growth arrest. Inactivation of p53 and Rb allows cells to bypass senescence (Hara et al., 1991; d'Adda di Fagagna et al., 2003) ; however, continuous cellular proliferation promotes further telomere shortening and leads to crisis, which is characterized by rampant chromosomal instability and massive cell death (Counter et al., 1992) . Virally transformed human cells can escape crisis at low frequencies and achieve infinite replicative potential by activating telomerase or alternative telomere-lengthening mechanisms (Counter et al., 1994) . In fact, activation of telomerase by enforced hTert expression can avert senescence and crisis (Bodnar et al., 1998; Vaziri and Benchimol, 1998) and grant full malignant transformation of primary human cells transfected with an oncogene (Hahn et al., 1999; Zhu et al., 1999) . Furthermore, the enforced expression of mTert in basal keratinocytes using the bovine keratin 5 promoter resulted in the increased susceptibility of tumor development on stimulation by chemical carcinogen (Gonzalez-Suarez et al., 2001) . Mice with transgenic Tert expression under the control of b-actin promoter also had increased incidence of spontaneous mammary tumors as they age . Coexpression of tumor suppressors p53, p16 and p19ARF in transgenic mice improved the fitness of epithelial barriers while attenuating the cancer-promoting effect of Tert (Tomas-Loba et al., 2008) . Interestingly, tumor progression and dissemination by the constitutive expression of Tert was not dependent on telomere maintenance by telomerase as shown in Lck-Tert transgenic mice (Canela et al., 2004) , suggesting that Tert per se may have a role in tumor progression and dissemination.
Telomerase-deficient (mTerc À/À ) mice have been invaluable in providing insights into the dual effects of telomere dysfunction in tumorigenesis in the context of a mammalian system (Blasco et al., 1997; Rudolph et al., 1999) . In this model, mTerc þ /À mice (generation 0 or G0) are intercrossed to generate generation 1 (G1) mTerc À/À animals. G1 Â G1 crosses yield G2 mice, G2 crosses yield G3 mice and so on. As these animals lack telomerase activity, telomeres in germ cells are not 'reset' and therefore, each generation harbors telomeres that are shorter than the earlier one. In late generations of mTerc À/À mice, telomere attrition is extremely pronounced. In the setting of an intact p53 pathway, telomerase dysfunction results in end-to-end chromosome fusions (Blasco et al., 1997) and activation of the DNA damage response pathway, leading to tumor suppression as a result of increased cellular apoptosis and senescence Gonzalez-Suarez et al., 2000; Farazi et al., 2003; Cosme-Blanco et al., 2007) . Loss of p53, on the other hand, creates a permissive environment in which critically short telomeres are inappropriately joined, resulting in genomic instability characterized by the formation of complex nonreciprocal translocations, loss of heterozygosity, gene amplifications, deletions and aneuploidy O'Hagan et al., 2002; Artandi and Attardi, 2005; Maser et al., 2007) . In this context, telomere dysfunction promotes the initiation of neoplasia by fueling the acquisition of oncogenic mutations. have elegantly shown that heterozygous loss of p53 in late generation mTerc À/À mice leads to the development of a 'humanized' spectrum of epithelial carcinomas, whereas homozygous loss of p53 in these animals leads to increased incidence of lymphomas. The tumor suppression effect of short telomeres is not affected by ATM and Ink4a/Arf deficiency, as delayed onset or decreased incidence of tumors or both were still observed in Atm Qi et al., 2003 Qi et al., , 2005 and Ink4a/Arf (Greenberg et al., 1999; Khoo et al., 2007) , respectively. The tumor suppressor activity of short telomeres is also abolished in mTerc À/À mice with deficiency of MSH2, a component in the mismatch repair (MMR) pathway (Martinez et al., 2009) , WRN (Chang et al., 2004) or TRF2 overexpression . In contrast, deletion of PMS2, another component in MMR, in mTerc À/À mice reduced the tumor incidence of lymphomas, sarcomas and colon cancer (Siegl-Cachedenier et al., 2007) . Deletion of p21 or the DNA repair proteins, Ku80 and DNA-PKcs, respectively, in the background of telomerase deficiency has a negligible effect on tumorigenesis (Espejel et al., 2004; Choudhury et al., 2007) . In the context of SV40 or HPV16 oncogeneinitiated tumorigenesis, telomerase activity seems to be readily bypassed, with lesions being highly tolerant of short telomeres (Argilla et al., 2004) . Finally, transformed late passage mTerc À/À Ink4a/Arf À/À embryonic fibroblasts form subcutaneous tumors despite high levels of telomere dysfunction. However, even moderate levels of telomere dysfunction completely abrogate the capacity of these cells to form lung metastases (Chang et al., 2003) . These results underline the complex role of telomerase and telomere maintenance in tumorigenesis.
Given that telomere dysfunction affects tumorigenesis in a manner that is highly dependent on driver lesions, tumor suppressor background and tumor type (Artandi and DePinho, 2000) , we set out to examine the role of telomerase activity in the development and progression of polyomavirus middle T oncogene (PyMT)-induced mammary carcinomas. PyMT is a potent oncogene that binds to and co-opts several signal transduction pathways, including those of the Src family and the ras and PI3 kinase pathways, which are altered in human breast cancers. We crossed mice in the C57BL/6 strain carrying the PyMT oncogene under the mouse mammary tumor virus LTR (MMTV-LTR) promoter (MMT mice) (Chen et al., 2003; Xia et al., 2003) with mTerc À/À animals. A significant reduction in mammary carcinomas was observed in the late generations of mTerc À/À MMT mice. These results indicate that telomere maintenance and telomerase activity are significant in the development and progression of PyMT-initiated mammary carcinomas.
Results
Association of mammary tumor formation with telomerase activity Approximately 90% of malignant tumors express telomerase (Kim et al., 1994) . To assess the role of telomerase activation in the tumorigenesis of MMT mice, we harvested mammary glands at different stages of tumor development and examined for tumor formation and telomerase activity. In the PyMT-negative mice, mammary ducts are lined by a single layer of luminal epithelial cells (Figure 1a) . In contrast, mammary ducts of MMT mice at an age of 4 weeks are lined by more than one layer of luminal epithelial cells, with the duct lumens still visible (Figure 1a ). An extensive formation of side buds and of a dilated ductal system is observed at this stage as well. Sustained proliferation results in the accumulation of epithelial cells within duct lumens in 6-to 7-week-old MMT mice (Figure 1a ). These hyperplastic lesions evolve into mammary intraepithelial neoplasms (MINs), which are late stage premalignant lesions characterized by ducts and acini filled with solid sheets of cells (Figure 1a) . MINs progress into carcinoma in situ and finally diffuse invasive tumors by the age of 15 weeks (Figure 1a ). This typical staged progression from normal epithelial ducts and acini to mammary carcinomas is more apparent in the whole mount (Figure 1b) . In contrast, mammary trees and epithelia in wild-type mice remain unchanged with few side branches (Figures 1a and b) . These observations indicate that, as is the case for human breast cancer, PyMT-initiated mammary tumors develop in a multistage manner with a viable immune system backdrop.
To determine the relationship between telomerase activity and mammary tumor development, we harvested mammary glands from MMT mice at multiple time points and assayed for telomerase activity. A progressive increase was detected in mammary tissues from 1-to 6-month-old MMT mice, with telomerase activity first being detectable at 2-3 months of age (Supplementary Figure 1) . These findings suggest that the activation of telomerase may have a role in PyMTinitiated mammary tumorigenesis.
Inhibition of tumor development in MMT mice with telomerase deficiency
To further assess the role of telomerase in PyMTinitiated mammary carcinomas, a loss-of-function approach was used. MMT mice increased from 122.6 ± 24 (G1) to 138.9 ± 19 (G2), 140.7 ± 30 (G3) to 220.9±80 days (G4). There was a statistically significant difference in tumor latency when G1-G4 mTerc 
Inhibition of mammary tumors associated with telomere dysfunction
The results discussed above suggest a critical role for telomere maintenance by telomerase in mammary tumor ), respectively, at the indicated days. Mice with no detectable tumor are assigned as (n). Each symbol represents one mouse. The mean latent time for tumor development from mTerc þ /À MMT and G1-G4 mTerc À/À MMT mice was compared with that from the MMT group using t-test. (c) Tumor or mammary glands from MMT, mTerc þ /À MMT and G1-G4 mTerc À/À MMT mice were processed for whole mount and stained with carmine alum. Whole mammary glands were photographed. Tumor masses are visualized as dark nodules. (d) The mammary glands and/or tumors from MMT, mTerc þ /À MMT and G1-G4 mTerc À/À MMT mice were sectioned, stained with hematoxylin and eosin (H&E) and examined under a microscope.
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formation. An inability to maintain telomere length above a critical threshold may exert inhibitory effects in PyMT-mediated tumorigenesis. To assess the relationship between tumor growth and telomere length, we harvested mammary tumors from MMT, mTerc
MMT and G1-G4 mTerc À/À MMT mice and assayed for telomerase activity and telomere length. As expected, telomerase activity was detected in tumor samples from MMT and mTerc þ /À MMT mice; nevertheless, there was no detectable telomerase activity in the tumor samples from mTerc À/À MMT mice (Figure 3a) . In addition, a telomeric terminal restriction fragment (TRF) Southern blot revealed a progressive shortening of telomeres in tumor cells from MMT, mTerc þ /À MMT and G1-G4 mTerc À/À MMT mice (Figure 3b ). This assay shows that though the mean telomere length does not change significantly, long telomeric sequences (>48.5 kb) are increasingly rare in advancing generations, whereas MMT mice is likely because of the inhibitory effects of telomerase inactivation and telomere dysfunction.
Effect of telomerase deficiency and telomere dysfunction on proliferation and inactivation of tumor cells Telomerase deficiency and telomere dysfunction can result in impaired proliferation and increased apoptosis in tumor cells, leading to impaired tumorigenesis. To determine the mechanism through which telomerase deficiency and telomere dysfunction exert inhibitory effects on tumorigenesis, we examined the rates of proliferation and apoptosis in mammary tumors from MMT, G0 and G1-G3 mTerc À/À MMT mice using immunohistochemical staining with antibody against Ki67, a proliferation marker (Vasiljeva et al., 2008) , and terminal transferase dUTP nick-end labeling (TUNEL) assay. Although significant numbers of tumor cells from MMT and G0 mice are positive for Ki67, suggesting a robust proliferation pace, a progressive decrease in Ki67-positive cells was observed in tumors from G1 to G3 mTerc À/À MMT mice (Figures 4a and c) . Conversely, 
M Jaskelioff et al increased apoptosis was observed in these samples when compared with MMT or mTerc þ /À controls (Figures 4b  and d) . Thus, decreased rates of proliferation and increased apoptosis may be among the mechanisms through which telomerase deficiency and telomere dysfunction exert their inhibitory effect in mammary tumorigenesis.
Effect of telomerase deficiency and telomere dysfunction on cell-cycle regulation It is well established that denuded chromosome ends due to progressive telomere erosion are detected as dsDNA breaks that activate cell-cycle checkpoints. To determine whether DNA damage checkpoints are triggered in mTerc
MMT mammary tumors, we used immunohistochemical staining against g-H2AX (Figure 5a ). As expected, g-H2AX accumulates in discreet nuclear foci in G4 and, to a lesser extent, in G3 mTerc À/À MMT tumor cells, but not in cells with longer telomeres. We performed western blot analyses to ascertain the level of activation of p53-dependent cell-cycle checkpoints. Figure 5b shows that p53 is highly phosphorylated in G4 mTerc
MMT tumor cells and that the expression of key cell-cycle regulators (Mdm2, p21Cip1, p27Kip1, p16Ink4a) is accordingly upregulated, whereas that of p19ARF, a p53 repression target, is downregulated. The 53BP1 protein was detected at progressively higher levels in advancing generations, reflecting the accumulation of DNA damage in cells with shorter telomeres. Together, these results support a model of tumor suppression in a background of functional p53 in which cell-cycle checkpoints are activated in response to dysfunctional telomeres.
Progressive reduction of metastasis in mTerc
À/À
MMT mice
To determine whether telomerase is involved in tumor metastasis, we examined mouse lungs using a combination of histological examination and clonogenic assay. Metastasis was found in lung tissue collected from MMT and mTerc þ /À MMT mice, whereas we did not detect tumor metastasis in the sections of lungs from G1 to G4 mTerc À/À MMT mice (Figure 6a ). As small metastases may be missed by histological examination, clonogenic assays were carried out in excised lung tissue in parallel. Numerous colonies of tumor cells were detected in lung cultures from MMT and mTerc þ /À MMT mice, whereas a progressive reduction of tumor cell colonies derived from metastatic cells was observed in lung cultures from mTerc À/À MMT (G1-G3) mice; no metastases were found in the lungs from G4 mTerc À/À MMT mice (Figure 6b ). Clonogenic assay is evidently a more sensitive method to detect disseminated cancer Role of telomerase in mammary carcinomas M Jaskelioff et al cells compared with histological examination. To quantify such pulmonary metastasis, tumor cell colonies from each culture were counted and analysed. As shown in Figure 6c , the number of clonogenic tumor cells was progressively reduced in the lung cultures from G1 to G3 mTerc À/À MMT mice and no tumor colonies were observed from G4 mTerc À/À MMT mice. The decline in the numbers of tumor colonies between MMT mice and G1, G2 or G3 mTerc À/À MMT mice is statistically significant, suggesting that distant metastasis in mTerc À/À MMT mice is progressively impaired. The decline in lung metastasis in mTerc À/À MMT mice may reflect the lack of telomerase activity and telomere attrition in tumor cells.
Discussion
Our data suggest a role for the ribonucleoprotein telomerase in PyMT-initiated mammary tumorigenesis. We generated MMT mice deficient in telomerase activity to examine this relationship. As mice possess abundant telomere reserves, four sequential generations of mTerc À/À MMT mice were bred, each harboring telomeres shorter than the earlier generation. This mouse model recapitulates the dynamic relationships between tumor initiation, progression and telomere attrition existing in human cancer. As expected, knockout of the RNA component of telomerase in mTerc À/À MMT mice results in a loss of telomerase activity, leading to þ /À MMT and G1-G4 mTerc À/À MMT mice when they were killed at the indicated ages. Lungs were prepared for sections that were stained with hematoxylin and eosin (H&E) and then examined under a microscope. (b) Clonogenic assay of lung metastasis. Lungs harvested from MMT, mTerc þ /À MMT and G1-G4 mTerc À/À MMT mice were minced and digested in the collagenase enzyme cocktail solution. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) medium supplemented with 10% fetal calf serum (FCS) for 2 weeks and stained with an anti-MUC1 antibody using standard immunohistochemical staining methods. Tumor colonies with MUC1 expression are considered as tumor metastasis. (c) Statistical analysis of lung metastasis from MMT (n ¼ 5), mTerc þ /À MMT (n ¼ 5) and G1-G4 mTerc -/-MMT (n ¼ 3-5) mice. Tumor colonies from the lung cultures of each mouse were counted and are represented in the bar graph. The mean of tumor colonies from mTerc þ /À MMT and G1-G4 mTerc À/À MMT mice was compared with that from MMT mice using t-test.
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M Jaskelioff et al the progressive shortening of telomeres at each cell division. Our data indicate that telomerase deficiency and telomere attrition are associated with impairment of mammary carcinomas in mTerc À/À MMT mice. In addition, the severity of tumor inhibition was directly correlated with the number of generations of mTerc À/À MMT mice. Mild to moderate inhibition of mammary tumors was observed in the early generations, whereas impairment of tumor development was severe in late generation mice, culminating in the complete absence of tumor in some G4 mice (Figure 2) .
In MMT mice, the activation of telomerase was coincident with the timing of malignant transformation of mammary tumors, suggesting that the activation of telomerase may be an additional genetic or epigenetic alteration required for the development of mammary carcinomas. Our results show that telomerase activity may not be required in the malignant transformation of mammary epithelia as tumor formation in G1-G3 mice, though impaired, was observed. However, the failure to detect mammary tumors in some G4 mice indicates the importance of telomere length in the formation of tumors. It is possible that optimal tumorigenesis requires a vigorous proliferation of ductal epithelial cells with telomeres being continuously lengthened over critical thresholds by telomerase. Proliferation of epithelial cells, and subsequently of tumor cells, is evidently impaired when telomere reserves are depleted in the absence of telomerase. Therefore, diminished proliferation due to depleted telomere reserves stalls PyMT-initiated mammary tumorigenesis. This impairment in the proliferation of mTerc À/À MMT tumor cells was also observed in vitro (data not shown). These experiments provide evidence that telomerase is involved in tumorigenesis mainly through the maintenance of telomeres in tumor cells, though other telomere-independent telomerase activities cannot be excluded because tumor formation in G1 and G2 mice was also impaired.
Interestingly, our data suggest that telomerase may have a direct role in metastasis. Lung metastases in MMT and mTerc þ /À MMT mice were readily found both by histological examination and by clonogenic assay (Figure 6 ). In contrast, we did not find metastases in lung sections from mTerc À/À MMT mice, regardless of the generation. Small numbers of tumor colonies were observed in the culture of lungs from G1 to G3, but not G4 mTerc À/À MMT mice. In addition, these tumor colonies may be derived from tumor cells in the circulation rather than from tumor cells colonizing the lung tissue. These results are consistent with earlier findings indicating that telomerase is needed for tumor metastasis (Chang et al., 2003; Sun et al., 2004) .
The impairment in tumorigenesis observed in mTerc
MMT mice might be the result of the decreased proliferation or increased apoptosis of tumor cells (Farazi et al., 2003; Perera et al., 2008 MMT mice may mask the apoptosis resulting from telomere dysfunction. Alternatively, these results might reflect the fact that telomere shortening triggers cell-cycle arrest in the G 1 phase of the cell cycle (cellular senescence), as indicated by the upregulation of key cellcycle regulators (Figure 5 ), but this arrest is not necessarily followed by the activation of programmed cell death cascades.
Although telomerase deficiency and subsequent telomere dysfunction inhibit the formation of mammary tumors, we also observed detrimental effects in mitotically active normal cells such as germ cells (Supplementary Figure 2 ). As a consequence of this systemic effect on normal tissues, we were only able to generate mTerc À/À MMT mice in the C57BL6 strain for four generations. This finding is consistent with earlier reports showing that MEFs from mTerc À/À embryos on a C57BL6 background possess significantly shorter telomeres than those derived from mTerc À/À embryos on the mixed C57BL6/129Sv background (Herrera et al., 1999) .
In conclusion, telomerase is pivotal in PyMT-initiated mammary tumorigenesis. Telomerase is required to maintain the telomere length and to fuel the proliferation of mammary epithelial and tumor cells, directly or indirectly, and is needed for the development of mammary tumors and pulmonary metastasis.
Materials and methods

Mice
PyMT expressing MT mice were mated to MUC1 transgenic (MUC1.Tg) mice to produce MMT mice (Rowse et al., 1998; Xia et al., 2003) . mTerc MMT mice. Animals were maintained in microisolator cages under specific pathogen-free conditions. From 6 weeks on, the mice were examined by palpation weekly for the occurrence of mammary tumors.
Assessment of telomerase activity
A Trapeze telomerase detection kit was used to determine telomerase activity as recommended by the manufacturer (Chemicon, Temecula, CA, USA). The PCR products were electrophoresed on a 12.5% polyacrylamide nondenaturing Role of telomerase in mammary carcinomas M Jaskelioff et al gel, dried and exposed to a Biomax MR film (Kodak, Rochester, NY, USA) for 18 h.
Assessment of telomere length by telomeric repeat fragment Southern blot
The TRF Southern blot was performed as described earlier (Canela et al., 2007) , with the following modifications: DNA was digested in-plug with 70 U each of HinfI and RsaI, in NEB2 buffer (New England Biolabs, Ipswich, MA, USA). The gel probed by 32P-labeled (TTAGGG) 6 telomeric probe (500 000 counts per ml) was exposed to a Biomax MR film (Kodak) for 18 h. Densitometric analysis of the autoradiograph was performed using ImageJ software (Bethesda, MD, USA, Rasband, 1997 Rasband, -2008 .
Histological examination with whole-mount and H&E staining Mice were killed at the indicated times. For whole-mount preparation, mammary glands were harvested and resected tissue was spread onto a slide and fixed in Carnoy's fixative (60% ethanol, 30% chloroform, 10% glacial acetic acid) for 2-4 h at 4 1C. The tissue mount was washed in 70% ethanol for 15 min, 50% ethanol for 15 min, rinsed with distilled water for 5 min and placed in a carmine alum staining solution overnight. Stained whole mammary glands were kept in 70% ethanol at 4 1C for photography. For H&E staining, mammary glands were paraffin-embedded, sectioned (5 mm), stained with H&E and examined under a light microscope.
Immunohistochemical staining and TUNEL assay
To identify proliferative cells or cells undergoing DNA damage, sections of mammary tumors from MMT, G0 mTerc þ /À MMT and G1 to G3 mTerc À/À MMT mice were stained with monoclonal antibody against Ki67 (Dako A/S, Hamburg, Germany) or polyclonal antibody against g-H2AX (Bethyl Laboratories, Montgomery, TX, USA) using the standard immunohistochemical staining method. The slides were examined under a microscope. To determine apoptosis in mammary tumor cells, TUNEL staining was performed using the ApopTag Plus peroxidase kit (Chemicon) in a method described earlier with some modification (Chen et al., 2000) . To quantify the proliferation and apoptosis in tumor cells, we selected 3 to 5 high-power fields per mouse and Ki67-positive and apoptotic cells were counted by two independent investigators. The percentage of Ki67-positive and apoptotic cells from each group of mice was compared. 
Western blotting
Western blots were performed following standard techniques. Antibodies used were Mdm2 (BD Pharmingen, San Jose, CA, USA), 53BP1 (Bethyl Laboratories), phospho-p53 (Cell Signaling Technologies, Danvers, MA, USA), p53 (Vector Laboratories, Burlingame, CA, USA), p27 (Cell Signaling Technologies), p21 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), p19 (Abcam, Cambridge, MA, USA), p16 (Santa Cruz Biotechnology), Actin (Biolegend, San Diego, CA, USA). HRP-conjugated secondary antibodies from Pierce/ThermoScientifics (Pittsburgh, PA, USA) (anti-mouse, PI31430 and anti-rabbit, PI31460) were used.
Clonogenic assay for lung metastases
Freshly harvested lungs were minced and digested in collagenase enzyme cocktail solution as described earlier (Pulaski and Ostrand-Rosenberg, 1998) . Single cells were cultured in 10% fetal calf serum (FCS) supplemented with Dulbecco's modified Eagle's medium (DMEM) medium for 2 weeks and stained with an anti-MUC1 antibody (BD Pharmingen) using standard immunohistochemical techniques. Tumor metastases were determined by the growth of tumor colonies with MUC1 expression in the plate. Each MUC1-positive colony was counted to quantify the metastases for each individual mouse.
Statistical analysis
Statistical significance was analysed using w 2 -test or Student's t-test. Po0.05 indicates statistical significance.
